title: The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
abstract: BACKGROUND
  This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder.
  
  
  METHODS
  A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence-based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms.
  
  
  RESULTS
  The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis.
  
  
  CONCLUSIONS
  These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.
authors: College of Pharmacy, University of Texas at Austin, 78712, USA.
authors: M L
authors: ML
authors: Crismon
authors: M
authors: M
authors: Trivedi
authors: T A
authors: TA
authors: Pigott
authors: A J
authors: AJ
authors: Rush
authors: R M
authors: RM
authors: Hirschfeld
authors: D A
authors: DA
authors: Kahn
authors: C
authors: C
authors: DeBattista
authors: J C
authors: JC
authors: Nelson
authors: A A
authors: AA
authors: Nierenberg
authors: H A
authors: HA
authors: Sackeim
authors: M E
authors: ME
authors: Thase
mesh_terms: D000465:Algorithms; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003156:Community Mental Health Services / Q000592:standards; D003663:Decision Trees; D003866:Depressive Disorder / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006801:Humans; D013781:Texas
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents